Gene · 2145
Papers1,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploiting an epigenetic resistance mechanism to PI3-kinase inhibition in leukemic stem cells. | Leukemia | 2026 | 42806054 | PubTator, text mining | PubMed |
| Biallelic EZH1 Nonsense Novel Variant in Two Siblings with Neurodevelopmental Disorder and Central Precocious Puberty: A Case Report from a Consanguineous Saudi Family. | Int J Mol Sci | 2026 | 42653090 | PubTator, text mining | PubMed |
| Thyroid cancer-associated EZH1 Q571R mutation drives chromatin compaction and H3K27me3 invasion into active chromatin. | Mol Cell | 2026 | 42398503 | PubTator, text mining | PubMed |
| Allosteric Inhibition of Polycomb Repressive Complex 2 by an EZH2-Selective Small Molecule Inhibitor. | Adv Sci (Weinh) | 2026 | 42314051 | PubTator, text mining | PubMed |
| Impaired bone matrix turnover with selective small bone fragility in a child with TENT5A-associated osteogenesis imperfecta. | JBMR Plus | 2026 | 41908159 | PubTator, text mining | PubMed |
| RNA N6-methyladenosine (m6A) regulates cell cycle progression in diffuse midline glioma (DMG) and confers sensitivity to FTO inhibition. | Cell Death Dis | 2026 | 41888518 | PubTator, text mining | PubMed |
| 3D Soft Hydrogels Induce Human Mesenchymal Stem Cells "Deep" Quiescence. | Adv Healthc Mater | 2026 | 41834288 | PubTator, text mining | PubMed |
| Combinational Inhibition of the eIF4F Complex, AKT1, and EZH2 Enhances Anticancer Effects in BRAFV600E Mutant A375 Melanoma Cells. | Oncol Res | 2026 | 41799498 | PubTator, text mining | PubMed |
| Circular RNAs in sepsis-induced acute lung injury: emerging mechanisms and therapeutic potential. | Front Immunol | 2026 | 41789098 | PubTator, text mining | PubMed |
| Impact of Co-Mutations and Genetic Variations on Malignancy Risk in RAS-Positive Indeterminate Thyroid Nodules: an Institutional Experience. | Endocr Pathol | 2026 | 41784850 | PubTator, text mining | PubMed |
| Genome-wide DNA methylation changes after 24 hours at high altitude. | Environ Epigenet | 2026 | 41777793 | PubTator, text mining | PubMed |
| Clinical Importance of Molecular Biomarkers in Pleural Mesothelioma. | Cancers (Basel) | 2026 | 41749932 | PubTator, text mining | PubMed |
| Human Leukocyte Antigen (HLA) and Tumor Immunity: A Critical Link in Cancer Immunotherapy. | Immun Inflamm Dis | 2026 | 41699399 | PubTator, text mining | PubMed |
| DNA methylation landscapes in human cells and their chromatin determinants. | Ageing Cancer Res Treat | 2026 | 41641439 | PubTator, text mining | PubMed |
| Proteomic analysis of corneal epithelial cells in patients with neurotrophic keratopathy. | Exp Eye Res | 2026 | 41628806 | PubTator, text mining | PubMed |
| Defining the heterogeneous molecular landscape of lung cancer cell responses to epigenetic inhibition. | Commun Biol | 2026 | 41606085 | PubTator, text mining | PubMed |
| Therapeutic horizons in the development of PROTAC-based EZH2 inhibitors: recent achievements, comparative analysis, and future perspectives. | RSC Adv | 2026 | 41541203 | PubTator, text mining | PubMed |
| Unraveling the many faces of angioimmunoblastic T-cell lymphoma: clinical, pathological, and molecular heterogeneity. | Ann Hematol | 2026 | 41535417 | PubTator, text mining | PubMed |
| Multi-omics to study chronic respiratory diseases and viral infections. | Eur Respir Rev | 2026 | 41534886 | PubTator, text mining | PubMed |
| Polycomb repressive complexes as therapeutic targets in hematologic malignancies. | Exp Hematol | 2026 | 41443386 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2145/papers